Literature DB >> 6321700

A new imaging agent for medullary carcinoma of the thyroid.

H Ohta, K Yamamoto, K Endo, T Mori, D Hamanaka, A Shimazu, K Ikekubo, K Makimoto, Y Iida, J Konishi.   

Abstract

Thyroid scintigraphy, using 99mTc(V) dimercaptosuccinic acid, was performed in four patients with pathologically confirmed medullary thyroid carcinoma and elevated serum calcitonin values. Significant uptake of the tracer was found in the clinically palpable cervical tumor masses, metastatic sites, and residual tumor. This finding, probably specific for medullary thyroid carcinoma, could be of great use in the diagnosis and the surgical follow-up.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321700

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  27 in total

1.  Positive imaging of cardiomyopathy with 99mTc(V)-DMSA.

Authors:  H Ohta; T Komibuchi; S Kawamata; K Yamamoto; M Shichirousako; T Wada; H Kotoura; K Shizuki; K Endo; J Konishi
Journal:  Ann Nucl Med       Date:  1992-11       Impact factor: 2.668

2.  99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma.

Authors:  A Miyauchi; K Endo; H Ohta; K Torizuka; F Matsuzuka; A Kobayashi; K Kuma; M Maeda
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

3.  Search for polynuclear pentavalent technetium complex of dimercaptosuccinic acid [Tc(V)-DMS] tumour localization mechanism. I. Medullary thyroid carcinoma animal model.

Authors:  K Horiuchi; I Yomoda; H Ohta; K Endo; A Yokoyama
Journal:  Eur J Nucl Med       Date:  1991

4.  In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.

Authors:  A S Lam; M R Puncher; P J Blower
Journal:  Eur J Nucl Med       Date:  1996-12

5.  Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.

Authors:  H Kobayashi; K H Suzuki; H Sakahara; Z S Yao; A Yokoyama; J Konishi
Journal:  Eur J Nucl Med       Date:  1995-06

6.  Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.

Authors:  C H Kao; S J Wang; S P Wey; L H Shen; G Ting; S H Yeh
Journal:  Eur J Nucl Med       Date:  1992

7.  Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report.

Authors:  M Koizumi; T Watari; K Hirabayashi
Journal:  Ann Nucl Med       Date:  1993-02       Impact factor: 2.668

8.  Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.

Authors:  T Hirano; K Tomiyoshi; Y J Zhang; T Ishida; T Inoue; K Endo
Journal:  Eur J Nucl Med       Date:  1994-01

9.  Solitary muscular sarcoidosis: CT, MRI, and scintigraphic characteristics.

Authors:  H Kobayashi; Y Kotoura; H Sakahara; T Yamamuro; K Endo; J Konishi
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

Review 10.  Drug therapy alternatives in the treatment of thyroid cancer.

Authors:  M J O'Doherty; A J Coakley
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.